# Interstitial Photodynamic Therapy in Treating Patients With Recurrent Head and Neck Cancer

> **NCT02068157** · PHASE2 · TERMINATED · sponsor: **Roswell Park Cancer Institute** · enrollment: 3 (actual)

## Conditions studied

- Recurrent Laryngeal Squamous Cell Carcinoma
- Recurrent Laryngeal Verrucous Carcinoma
- Recurrent Lip and Oral Cavity Squamous Cell Carcinoma
- Recurrent Metastatic Squamous Cell Carcinoma in the Neck With Occult Primary
- Recurrent Oral Cavity Verrucous Carcinoma
- Recurrent Oropharyngeal Squamous Cell Carcinoma
- Tongue Carcinoma

## Interventions

- **OTHER:** Laboratory Biomarker Analysis
- **DRUG:** Photodynamic Therapy
- **DRUG:** Porfimer Sodium

## Key facts

- **NCT ID:** NCT02068157
- **Lead sponsor:** Roswell Park Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-04-01
- **Primary completion:** 2016-10-13
- **Final completion:** 2016-11-04
- **Target enrollment:** 3 (ACTUAL)
- **Why stopped:** Study no longer has an active IDE
- **Last updated:** 2017-10-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02068157

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02068157, "Interstitial Photodynamic Therapy in Treating Patients With Recurrent Head and Neck Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02068157. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*